Verdicts genuinely change. Free email alert the moment RXL's does — no target price to set, unlike "Alert" above.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
ProShares Ultra Health Care · ProShares Trust
70 holdings
This fund holds short positions, so exposure is counted gross — long and short both count as exposure rather than netting off, and the weights below therefore sum to 107% of net assets rather than 100%. Shares of the portfolio are shown as shares of that gross exposure.
UNVERIFIED 9% of this fund's gross exposure is short across 5 positions. Our look-through asks what a fund owns and whether owning it is permissible; a short position is not ownership but an obligation to deliver something the fund does not hold, so a verdict computed as though this were a long-only portfolio would not describe it. The holdings are listed below, with the short positions marked.
70 holdings, 59 matched (73% of weight). Portfolio as of 2026-05-31, filed 2026-07-28. Source: SEC Form N-PORT.
0.85% of this portfolio’s income is non-permissible — weighted across holdings, computed over 63% of portfolio weight (53 of 70 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
Portfolio shares are withheld: coverage is below the floor needed to state one. The holdings themselves are below, because the names are evidence you can check.
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| LLY Eli Lilly & Co. | COMPLIANT | 12.67% | AAOIFI5.2% Usmani38.6% Dow Jones Islamic6.4% S&P Shariah6.9% MSCI Islamic38.6% MSCI Islamic M-Series6.9% FTSE Shariah38.6% |
| ProShares GENIUS Money Market ETF | UNSCREENED | 11.81% | no in-house ratios for this holding |
| JNJ Johnson & Johnson | COMPLIANT | 7.86% | AAOIFI7.6% Usmani24.4% Dow Jones Islamic10.9% S&P Shariah11.7% MSCI Islamic24.4% MSCI Islamic M-Series11.7% FTSE Shariah24.4% |
| ABBV AbbVie, Inc. | COMPLIANT | 5.57% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| UNH UnitedHealth Group, Inc. | NON_COMPLIANT | 4.98% | AAOIFI20.4% Usmani23.7% Dow Jones Islamic20.4% S&P Shariah18.8% MSCI Islamic23.7% MSCI Islamic M-Series18.8% FTSE Shariah23.7% |
| MRK Merck & Co., Inc. | COMPLIANT | 4.26% | AAOIFI14.7% Usmani41.5% Dow Jones Islamic21.8% S&P Shariah20.9% MSCI Islamic41.5% MSCI Islamic M-Series20.9% FTSE Shariah41.5% |
| N/A | UNSCREENED | 4.13% | no in-house ratios for this holding |
| N/A | UNSCREENED | 3.97% | no in-house ratios for this holding |
| Repurchase Agreement | UNSCREENED | 2.91% | no in-house ratios for this holding |
| TMO Thermo Fisher Scientific, Inc. | COMPLIANT | 2.68% | AAOIFI20.5% Usmani40.3% Dow Jones Islamic23.4% S&P Shariah22.9% MSCI Islamic40.3% MSCI Islamic M-Series22.9% FTSE Shariah40.3% |
| AMGN Amgen, Inc. | COMPLIANT | 2.62% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| GILD Gilead Sciences, Inc. | COMPLIANT | 2.41% | AAOIFI14.4% Usmani53.2% Dow Jones Islamic18.6% S&P Shariah21.4% MSCI Islamic53.2% MSCI Islamic M-Series21.4% FTSE Shariah53.2% |
| ISRG Intuitive Surgical, Inc. | COMPLIANT | 2.18% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| PFE Pfizer, Inc. | NON_COMPLIANT | 2.15% | AAOIFI39.8% Usmani31.4% Dow Jones Islamic46.1% S&P Shariah45.9% MSCI Islamic31.4% MSCI Islamic M-Series45.9% FTSE Shariah31.4% |
| ABT Abbott Laboratories | COMPLIANT | 2.15% | AAOIFI19.2% Usmani31.9% Dow Jones Islamic17.6% S&P Shariah18.3% MSCI Islamic31.9% MSCI Islamic M-Series18.3% FTSE Shariah30.8% |
| Repurchase Agreement | UNSCREENED | 1.83% | no in-house ratios for this holding |
| BMY Bristol-Myers Squibb Co. | NON_COMPLIANT | 1.68% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| CVS CVS Health Corp. | NON_COMPLIANT | 1.67% | AAOIFI61.7% Usmani30.1% Dow Jones Islamic84.9% S&P Shariah88.7% MSCI Islamic30.1% MSCI Islamic M-Series88.7% FTSE Shariah24.2% |
| DHR Danaher Corp. | COMPLIANT | 1.66% | AAOIFI18.2% Usmani28.8% Dow Jones Islamic17.7% S&P Shariah16.7% MSCI Islamic28.8% MSCI Islamic M-Series16.7% FTSE Shariah28.8% |
| VRTX Vertex Pharmaceuticals, Inc. | COMPLIANT | 1.64% | AAOIFI1.6% Usmani7.2% Dow Jones Islamic1.7% S&P Shariah1.7% MSCI Islamic7.2% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| SYK Stryker Corp. | COMPLIANT | 1.52% | AAOIFI14.6% Usmani32.2% Dow Jones Islamic11.3% S&P Shariah11.8% MSCI Islamic32.2% MSCI Islamic M-Series11.8% FTSE Shariah31.2% |
| Repurchase Agreement | UNSCREENED | 1.37% | no in-house ratios for this holding |
| MDT Medtronic plc | COMPLIANT | 1.37% | AAOIFI24.4% Usmani31.5% Dow Jones Islamic26.4% S&P Shariah27.4% MSCI Islamic31.4% MSCI Islamic M-Series27.4% FTSE Shariah30.2% |
| MCK McKesson Corp. | COMPLIANT | 1.32% | AAOIFI12.5% Usmani14.9% Dow Jones Islamic14.5% S&P Shariah15.8% MSCI Islamic14.7% MSCI Islamic M-Series15.8% FTSE Shariah12.5% |
| ELV Elevance Health, Inc. | NON_COMPLIANT | 1.26% | AAOIFI35.1% Usmani24.6% Dow Jones Islamic37.4% S&P Shariah33.5% MSCI Islamic24.6% MSCI Islamic M-Series33.5% FTSE Shariah24.6% |
| N/A | UNSCREENED | 1.24% | no in-house ratios for this holding |
| CI Cigna Group (The) | NON_COMPLIANT | 1.06% | AAOIFI42.7% Usmani20.3% Dow Jones Islamic40.5% S&P Shariah38.8% MSCI Islamic20.3% MSCI Islamic M-Series38.8% FTSE Shariah20.3% |
| BSX Boston Scientific Corp. | COMPLIANT | 1.04% | AAOIFI19.4% Usmani27.9% Dow Jones Islamic10.0% S&P Shariah10.9% MSCI Islamic27.9% MSCI Islamic M-Series10.9% FTSE Shariah27.9% |
| Repurchase Agreement | UNSCREENED | 1.01% | no in-house ratios for this holding |
| REGN Regeneron Pharmaceuticals, Inc. | COMPLIANT | 0.90% | AAOIFI2.4% Usmani6.5% Dow Jones Islamic3.0% S&P Shariah2.7% MSCI Islamic4.8% MSCI Islamic M-Series2.7% FTSE Shariah4.8% |
| HCA HCA Healthcare, Inc. | NON_COMPLIANT | 0.86% | AAOIFI57.2% Usmani82.9% Dow Jones Islamic53.5% S&P Shariah56.7% MSCI Islamic81.7% MSCI Islamic M-Series56.7% FTSE Shariah78.1% |
| COR Cencora, Inc. | COMPLIANT | 0.76% | AAOIFI18.9% Usmani14.0% Dow Jones Islamic20.8% S&P Shariah22.7% MSCI Islamic14.0% MSCI Islamic M-Series22.7% FTSE Shariah14.0% |
| EW Edwards Lifesciences Corp. | COMPLIANT | 0.73% | AAOIFI1.4% Usmani5.1% Dow Jones Islamic1.5% S&P Shariah1.5% MSCI Islamic5.1% MSCI Islamic M-Series1.5% FTSE Shariah4.3% |
| CAH Cardinal Health, Inc. | COMPLIANT | 0.67% | AAOIFI17.8% Usmani17.7% Dow Jones Islamic24.8% S&P Shariah28.7% MSCI Islamic17.4% MSCI Islamic M-Series28.7% FTSE Shariah15.5% |
| IDXX IDEXX Laboratories, Inc. | COMPLIANT | 0.65% | AAOIFI1.4% Usmani16.8% Dow Jones Islamic1.3% S&P Shariah1.3% MSCI Islamic16.8% MSCI Islamic M-Series1.3% FTSE Shariah13.1% |
| BDX Becton Dickinson & Co. | NON_COMPLIANT | 0.61% | AAOIFI33.4% Usmani33.1% Dow Jones Islamic30.8% S&P Shariah28.7% MSCI Islamic33.1% MSCI Islamic M-Series28.7% FTSE Shariah33.1% |
| A Agilent Technologies, Inc. | COMPLIANT | 0.55% | AAOIFI9.3% Usmani28.3% Dow Jones Islamic10.8% S&P Shariah10.7% MSCI Islamic28.3% MSCI Islamic M-Series10.7% FTSE Shariah28.3% |
| WAT Waters Corp. | COMPLIANT | 0.54% | AAOIFI14.1% Usmani21.2% Dow Jones Islamic21.2% S&P Shariah23.3% MSCI Islamic21.2% MSCI Islamic M-Series23.3% FTSE Shariah19.7% |
| HUM Humana, Inc. | NON_COMPLIANT | 0.53% | AAOIFI30.1% Usmani26.3% Dow Jones Islamic44.9% S&P Shariah38.8% MSCI Islamic26.3% MSCI Islamic M-Series38.8% FTSE Shariah25.3% |
| ZTS Zoetis, Inc. | NON_COMPLIANT | 0.47% | AAOIFI29.0% Usmani61.3% Dow Jones Islamic15.4% S&P Shariah14.0% MSCI Islamic61.3% MSCI Islamic M-Series14.0% FTSE Shariah60.0% |
| N/A | UNSCREENED | 0.46% | no in-house ratios for this holding |
| IQV IQVIA Holdings, Inc. | NON_COMPLIANT | 0.45% | AAOIFI36.7% Usmani55.2% Dow Jones Islamic47.8% S&P Shariah44.8% MSCI Islamic54.4% MSCI Islamic M-Series44.8% FTSE Shariah53.4% |
| BIIB Biogen, Inc. | COMPLIANT | 0.42% | AAOIFI21.2% Usmani22.5% Dow Jones Islamic27.5% S&P Shariah24.3% MSCI Islamic22.5% MSCI Islamic M-Series24.3% FTSE Shariah21.3% |
| GEHC GE HealthCare Technologies, Inc. | NON_COMPLIANT | 0.41% | AAOIFI34.9% Usmani28.5% Dow Jones Islamic30.2% S&P Shariah30.1% MSCI Islamic28.4% MSCI Islamic M-Series30.1% FTSE Shariah27.3% |
| DXCM DexCom, Inc. | COMPLIANT | 0.41% | AAOIFI4.1% Usmani21.7% Dow Jones Islamic4.7% S&P Shariah4.0% MSCI Islamic20.9% MSCI Islamic M-Series4.0% FTSE Shariah19.3% |
| CNC Centene Corp. | NON_COMPLIANT | 0.40% | AAOIFI50.5% Usmani19.4% Dow Jones Islamic62.6% S&P Shariah53.4% MSCI Islamic19.4% MSCI Islamic M-Series53.4% FTSE Shariah19.4% |
| RMD ResMed, Inc. | COMPLIANT | 0.40% | AAOIFI2.6% Usmani9.2% Dow Jones Islamic2.4% S&P Shariah2.6% MSCI Islamic9.2% MSCI Islamic M-Series2.6% FTSE Shariah7.4% |
| N/A | UNSCREENED | 0.39% | no in-house ratios for this holding |
| VEEV Veeva Systems, Inc. | NON_COMPLIANT | 0.38% | AAOIFI0.4% Usmani1.7% Dow Jones Islamic0.4% S&P Shariah0.4% MSCI Islamic1.7% MSCI Islamic M-Series0.4% FTSE Shariah0.0% |
| MTD Mettler-Toledo International, Inc. | COMPLIANT | 0.35% | AAOIFI7.8% Usmani57.5% Dow Jones Islamic8.0% S&P Shariah7.9% MSCI Islamic57.5% MSCI Islamic M-Series7.9% FTSE Shariah57.5% |
| WST West Pharmaceutical Services, Inc. | COMPLIANT | 0.34% | AAOIFI1.3% Usmani7.8% Dow Jones Islamic1.6% S&P Shariah1.4% MSCI Islamic7.7% MSCI Islamic M-Series1.4% FTSE Shariah5.0% |
| N/A | UNSCREENED | 0.31% | no in-house ratios for this holding |
| LH Labcorp Holdings, Inc. | COMPLIANT | 0.31% | AAOIFI25.4% Usmani36.5% Dow Jones Islamic31.6% S&P Shariah33.5% MSCI Islamic36.2% MSCI Islamic M-Series33.5% FTSE Shariah31.6% |
| DGX Quest Diagnostics, Inc. | COMPLIANT | 0.31% | AAOIFI24.4% Usmani37.7% Dow Jones Islamic32.1% S&P Shariah35.4% MSCI Islamic37.7% MSCI Islamic M-Series35.4% FTSE Shariah33.3% |
| STE STERIS plc | COMPLIANT | 0.30% | AAOIFI9.4% Usmani19.1% Dow Jones Islamic9.1% S&P Shariah9.3% MSCI Islamic19.1% MSCI Islamic M-Series9.3% FTSE Shariah17.6% |
| VTRS Viatris, Inc. | NON_COMPLIANT | 0.27% | AAOIFI65.8% Usmani38.9% Dow Jones Islamic100.2% S&P Shariah105.1% MSCI Islamic38.9% MSCI Islamic M-Series105.1% FTSE Shariah38.1% |
| MRNA Moderna, Inc. | NON_COMPLIANT | 0.24% | AAOIFI2.2% Usmani11.7% Dow Jones Islamic7.4% S&P Shariah5.1% MSCI Islamic11.4% MSCI Islamic M-Series5.1% FTSE Shariah5.4% |
| ZBH Zimmer Biomet Holdings, Inc. | NON_COMPLIANT | 0.24% | AAOIFI40.7% Usmani32.8% Dow Jones Islamic39.1% S&P Shariah36.3% MSCI Islamic32.8% MSCI Islamic M-Series36.3% FTSE Shariah32.8% |
| INCY Incyte Corp. | COMPLIANT | 0.23% | AAOIFI0.1% Usmani0.7% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.3% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| COO Cooper Cos., Inc. (The) | COMPLIANT | 0.17% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| RVTY Revvity, Inc. | COMPLIANT | 0.17% | AAOIFI23.1% Usmani27.9% Dow Jones Islamic27.9% S&P Shariah27.2% MSCI Islamic27.9% MSCI Islamic M-Series27.2% FTSE Shariah26.7% |
| ALGN Align Technology, Inc. | COMPLIANT | 0.17% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| SOLV Solventum Corp. | NON_COMPLIANT | 0.16% | AAOIFI32.5% Usmani37.1% Dow Jones Islamic39.6% S&P Shariah41.1% MSCI Islamic35.7% MSCI Islamic M-Series41.1% FTSE Shariah35.7% |
| PODD Insulet Corp. | COMPLIANT | 0.15% | AAOIFI9.6% Usmani30.0% Dow Jones Islamic5.3% S&P Shariah5.9% MSCI Islamic30.0% MSCI Islamic M-Series5.9% FTSE Shariah30.0% |
| BAX Baxter International, Inc. | NON_COMPLIANT | 0.14% | AAOIFI1.7% Usmani1.1% Dow Jones Islamic1.6% S&P Shariah1.4% MSCI Islamic1.1% MSCI Islamic M-Series1.4% FTSE Shariah0.0% |
| CRL Charles River Laboratories International, Inc. | COMPLIANT | 0.13% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| TECH Bio-Techne Corp. | COMPLIANT | 0.12% | AAOIFI2.5% Usmani11.2% Dow Jones Islamic3.0% S&P Shariah2.9% MSCI Islamic11.2% MSCI Islamic M-Series2.9% FTSE Shariah7.7% |
| UHS Universal Health Services, Inc. | NON_COMPLIANT | 0.12% | AAOIFI52.8% Usmani33.0% Dow Jones Islamic45.9% S&P Shariah48.2% MSCI Islamic33.0% MSCI Islamic M-Series48.2% FTSE Shariah30.4% |
| HSIC Henry Schein, Inc. | NON_COMPLIANT | 0.11% | AAOIFI36.7% Usmani32.3% Dow Jones Islamic41.6% S&P Shariah41.0% MSCI Islamic32.3% MSCI Islamic M-Series41.0% FTSE Shariah29.2% |
| DVA DaVita, Inc. | NON_COMPLIANT | 0.09% | AAOIFI119.4% Usmani75.7% Dow Jones Islamic119.5% S&P Shariah122.0% MSCI Islamic75.7% MSCI Islamic M-Series122.0% FTSE Shariah60.9% |
The published standards disagree about this fund by 25 points of portfolio weight — 59.6% of it passes AAOIFI, 34.5% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 59.6% ratios fail on 11.9% 36.0% not rated under AAOIFI
ratios pass on 37.6% ratios fail on 33.9% 36.0% not rated under Usmani
ratios pass on 57.8% ratios fail on 13.6% 36.0% not rated under Dow Jones Islamic
ratios pass on 59.2% ratios fail on 12.3% 36.0% not rated under S&P Shariah
ratios pass on 34.5% ratios fail on 38.5% 34.3% not rated under MSCI Islamic
ratios pass on 58.5% ratios fail on 12.9% 36.0% not rated under MSCI Islamic M-Series
ratios pass on 38.5% ratios fail on 32.9% 36.0% not rated under FTSE Shariah
59 of 70 listed holdings carry our own per-methodology verdicts (78% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 53 (68% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
Methodology breakdown computing — it will appear here on its own.
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
Computing the full ratio and business-activity breakdown for RXL — this runs off the critical path so the page paints first. It will appear here on its own.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 56.20 | NEUTRAL |
| Stochastic %K (14) | 84.49 | SELL |
| CCI (20) | 88.26 | NEUTRAL |
| Williams %R (14) | -15.51 | SELL |
| MACD (12,26,9) | 0.01 | BUY |
| ROC (10) | -0.40 | SELL |
| Momentum (10) | -0.24 | SELL |
| EMA (10) | 58.75 | BUY |
| SMA (10) | 58.69 | BUY |
| EMA (20) | 58.81 | BUY |
| SMA (20) | 58.76 | BUY |
| EMA (30) | 58.73 | BUY |
| SMA (30) | 58.94 | BUY |
| EMA (50) | 58.04 | BUY |
| SMA (50) | 59.01 | BUY |
| EMA (100) | 55.76 | BUY |
| SMA (100) | 54.99 | BUY |
| EMA (200) | 53.11 | BUY |
| SMA (200) | 51.93 | BUY |
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the performance of health care companies included in the S&P 500 Index. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.
Background via Yahoo Finance — informational, not part of the verdict.
No real edge — avoid
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | RANGING | 42 |
| 🕐 1H | NEUTRAL | 17 |
| ⏱ 15-Min | BULLISH | 68 |
| ⏲ 5-Min | RANGING | 205 |
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
The questions worth asking about any verdict on this page, answered plainly.
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
NO DATA 0 buys · 0 sells
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-10-06 · Asset managers net 906615 (+2612)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.